Find the report behind your next decision
Syndicated reports on market outlook, epidemiology, emerging therapies, current treatment and market access, across oncology, rare and non-oncology indications.
Save 10% when you start with a free sample
Preview the scope and sample pages of any report in the store, then get 10% off when you buy it.
Know exactly how many patients you can reach
Validated patient numbers, funnels and disease burden for 450+ indications across 30+ countries.
Payer insight in as little as three weeks
Payer research across 31+ markets to shape your pricing, reimbursement and launch strategy.
Know which assets to back before the budget is spent
Weigh every asset on clinical, commercial, regulatory and competitive evidence, and invest where value is highest.
Hear directly from the physicians who treat
Test your assumptions with interviews and surveys drawn from our 8,500+ physician expert panel.
Forecasts your team can plan a launch around
Patient-based forecasts that combine epidemiology, treatment dynamics, pricing and competition.
Every key congress, distilled for your team
Live coverage of major meetings such as ESMO 2026, with the data and takeaways that matter to you.
- 2,273 reports in the store
- Free sample with every report
- Delivered in 48 to 72 hours
Browse by report type
See Thelansis insights first in Google’s Top Stories when you search the topics you follow.
We tailor reports to the indication, markets and questions you need.
Not sure which report fits your question? Our team will point you to the right one.
- Emailclientsupport@thelansis.com
- Call+91 124 493 7605
- HoursMon to Fri, 08:00 to 20:00
Showing 1 to 10 of 2,273 reports
Loading...
Obstructive Sleep Apnea (OSA) – Emerging Therapy, with Unmet Needs and TPP Insights Report – 2026
Thelansis’s “Obstructive Sleep Apnea (OSA) Emerging Therapy, with Unmet Needs and TPP Insights Report – 2026″ provides a comprehensive analysis of the emerging competitive landscape, unmet needs, target product profiles...
VEXAS Syndrome – Emerging Therapy, with Unmet Needs and TPP Insights Report – 2026
Thelansis’s “VEXAS Syndrome Emerging Therapy, with Unmet Needs and TPP Insights Report – 2026″ provides a comprehensive analysis of the emerging competitive landscape, unmet needs, target product profiles (TPPs), trial d...
Antiphospholipid Syndrome (APS) – Emerging Therapy, with Unmet Needs and TPP Insights Report – 2026
Thelansis’s “Antiphospholipid Syndrome (APS) Emerging Therapy, with Unmet Needs and TPP Insights Report – 2026″ provides a comprehensive analysis of the emerging competitive landscape, unmet needs, target product profile...
Moderate to Severe Asthma – Emerging Therapy, with Unmet Needs and TPP Insights Report – 2026
Thelansis’s “Moderate to Severe Asthma Emerging Therapy, with Unmet Needs and TPP Insights Report – 2026″ provides a comprehensive analysis of the emerging competitive landscape, unmet needs, target product profiles (TPP...
Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma – Market Outlook, Epidemiology, Compet...
Thelansis’s “Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2026 To 2036" covers disease overview, epidemiology, drug utili...
Spinal Cord Injury (SCI) – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast...
Thelansis’s “Spinal Cord Injury (SCI) Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2026 To 2036" covers disease overview, epidemiology, drug utilization, prescription share analysis,...
Obstructive Sleep Apnea (OSA) – Market Outlook, Epidemiology, Competitive Landscape, and Market Fore...
Thelansis’s “Obstructive Sleep Apnea (OSA) Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2026 To 2036" covers disease overview, epidemiology, drug utilization, prescription share analy...
Systemic Lupus Erythematosus (SLE) – Market Outlook, Epidemiology, Competitive Landscape, and Market...
Thelansis’s “Advanced Colorectal Cancer Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2026 To 2036" covers disease overview, epidemiology, drug utilization, prescription share analysis...
Advanced Colorectal Cancer – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecas...
Thelansis’s “Advanced Colorectal Cancer Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2026 To 2036" covers disease overview, epidemiology, drug utilization, prescription share analysis...
Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer – Market Outlook, Epidemiology, Compe...
Thelansis’s “Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2026 To 2036" covers disease overview, epidemiology, drug util...
Can't find the exact report you need?
Tell us what you are looking for and we will tailor the research to your indication, markets and questions.
- Built around your indication and markets
- Scoped with our analysts
- A proposal you can share with your team
Prefer to talk it through? Email clientsupport@thelansis.com
Thanks, , we have your request
You asked for for covering . We will reply to .
- Report & Insights
- Strategy Products
Strategy Products
- Consulting Services
- Media
Media
